← Back to headlines
AbbVie Gains Approval for Decnupaz Drug
AbbVie has received approval for its new drug, Decnupaz, intended for the treatment of a rare hematologic malignancy.
27 May, 19:55 — 27 May, 19:55
Sources
Showing 1 of 1 sources
Related Stories
Nvidia Nears $14 Billion Acquisition Deal for AI Startup Hugging Face
41m ago
Renewed US-Iran Strikes Push Oil Prices Above $95 Amid Regional Tensions
55m ago
Bessent Defends Economic Pressure Strategy Against Iran and Tariff Proposals
1h ago
Casablanca Airport Sets Daily Passenger Record Amid Summer Travel Surge
1h ago